Hoang-Xuan K - Search Results

1

Interim FDG-PET improves treatment failure prediction in primary central nervous system Lymphoma: a LOC network prospective multicentric study.

Rozenblum L, Houillier C, Baptiste A, Soussain C, Edeline V, Naggara P, Soret M, Causse-Lemercier V, Willems L, Choquet S, Ursu R, Galanaud D, Belin L, Hoang-Xuan K, Kas A. Rozenblum L, et al. Among authors: hoang xuan k. Neuro Oncol. 2024 Feb 16:noae029. doi: 10.1093/neuonc/noae029. Online ahead of print. Neuro Oncol. 2024. PMID: 38366824

2

Ongoing protocols for non-AIDS primary central nervous system lymphoma.

Hoang-Xuan K, Delattre JY. Hoang-Xuan K, et al. J Neurooncol. 1999 Jul;43(3):287-91. doi: 10.1023/a:1006266821574. J Neurooncol. 1999. PMID: 10563435 Review.

3

Treatment of meningeal gliomatosis.

Pradat PF, Hoang-Xuan K, Cornu P, Mokhtari K, Martin-Duverneuil N, Poisson M, Delattre JY. Pradat PF, et al. J Neurooncol. 1999 Sep;44(2):163-8. doi: 10.1023/a:1006399804896. J Neurooncol. 1999. PMID: 10619500

4

Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.

Soussain C, Suzan F, Hoang-Xuan K, Cassoux N, Levy V, Azar N, Belanger C, Achour E, Ribrag V, Gerber S, Delattre JY, Leblond V. Soussain C, et al. J Clin Oncol. 2001 Feb 1;19(3):742-9. doi: 10.1200/JCO.2001.19.3.742. J Clin Oncol. 2001. PMID: 11157026 Clinical Trial.

5

Treatment of primary central nervous system lymphoma in the elderly.

Hoang-Xuan K, Chinot OL, Taillandier L. Hoang-Xuan K, et al. Semin Oncol. 2003 Dec;30(6 Suppl 19):53-7. doi: 10.1053/j.seminoncol.2003.11.032. Semin Oncol. 2003. PMID: 14765387 Review.

6

[Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma].

Soussain C, Hoang-Xuan K, Levy V. Soussain C, et al. Bull Cancer. 2004 Feb;91(2):189-92. Bull Cancer. 2004. PMID: 15047459 Free article. French.

7

Recent advances in primary CNS lymphoma.

Hoang-Xuan K, Camilleri-Broët S, Soussain C. Hoang-Xuan K, et al. Curr Opin Oncol. 2004 Nov;16(6):601-6. doi: 10.1097/01.cco.0000142927.88773.7e. Curr Opin Oncol. 2004. PMID: 15627024 Review.

8

New treatment approaches in primary central nervous system lymphoma.

Soussain C, Hoang-Xuan K, Doolittle ND. Soussain C, et al. Hematol Oncol Clin North Am. 2005 Aug;19(4):719-28, vii. doi: 10.1016/j.hoc.2005.05.007. Hematol Oncol Clin North Am. 2005. PMID: 16083832 Review.

9

Prognostic impact of molecular markers in a series of 220 primary glioblastomas.

Houillier C, Lejeune J, Benouaich-Amiel A, Laigle-Donadey F, Criniere E, Mokhtari K, Thillet J, Delattre JY, Hoang-Xuan K, Sanson M. Houillier C, et al. Cancer. 2006 May 15;106(10):2218-23. doi: 10.1002/cncr.21819. Cancer. 2006. PMID: 16568472 Free article.

10

Association of telomerase gene hTERT polymorphism and malignant gliomas.

Carpentier C, Lejeune J, Gros F, Everhard S, Marie Y, Kaloshi G, Laigle-Donadey F, Hoang-Xuan K, Delattre JY, Sanson M. Carpentier C, et al. J Neurooncol. 2007 Sep;84(3):249-53. doi: 10.1007/s11060-007-9378-3. Epub 2007 Apr 5. J Neurooncol. 2007. PMID: 17410334

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

339 results

Search Page